The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Contraceptives Market Outlook 2024

Global Contraceptives Market Outlook 2024

Publishing Date : Jan, 2022

License Type :
 

Report Code : 1634693

No of Pages : 117

Synopsis
Contraceptives are a kind of medicine used to prevent unwanted pregnancy. It consists of one or more synthetic female sex hormones. These sex hormones prevent pregnancy by blocking the normal process of ovulation.
Europe is the largest Contraceptives market with about 44% market share. North America is follower, accounting for about 37% market share.
The key players are Bayer AG, Pfizer, Inc, Teva Pharmaceutical Industries Ltd, Merck & Co., Inc, Actavis, Inc., Johnson & Johnson, Gedeon Richter, Novo Nordisk A/S, ZiZhu, Baijingyu, Huazhong, Sine etc. Top 3 companies occupied about 46% market share.

The global Contraceptives market was valued at US$ 1868.5 million in 2020 and is expected to reach US$ 2217.2 million by the end of 2027, growing at a CAGR of 2.5% during 2021-2027.
This report focuses on Contraceptives volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Contraceptives market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.

Global Contraceptives Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type
Prolonged Contraception
Short-term Contraception
Emergency Contraception

Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E

By Company
Bayer AG
Pfizer, Inc
Teva Pharmaceutical Industries Ltd
Merck & Co., Inc
Actavis, Inc.
Johnson & Johnson
Gedeon Richter
Novo Nordisk A/S
ZiZhu
Baijingyu
Huazhong
Sine
Index
1 Contraceptives Market Overview
1.1 Product Overview and Scope of Contraceptives
1.2 Contraceptives Segment by Type
1.2.1 Global Contraceptives Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Prolonged Contraception
1.2.3 Short-term Contraception
1.2.4 Emergency Contraception
1.3 Contraceptives Segment by Application
1.3.1 Global Contraceptives Sales Comparison by Application: (2021-2027)
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.3.5 Others
1.4 Global Contraceptives Market Size Estimates and Forecasts
1.4.1 Global Contraceptives Revenue 2016-2027
1.4.2 Global Contraceptives Sales 2016-2027
1.4.3 Contraceptives Market Size by Region: 2016 Versus 2021 Versus 2027

2 Contraceptives Market Competition by Manufacturers
2.1 Global Contraceptives Sales Market Share by Manufacturers (2016-2021)
2.2 Global Contraceptives Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Contraceptives Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Contraceptives Manufacturing Sites, Area Served, Product Type
2.5 Contraceptives Market Competitive Situation and Trends
2.5.1 Contraceptives Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Contraceptives Players Market Share by Revenue
2.5.3 Global Contraceptives Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Contraceptives Retrospective Market Scenario by Region
3.1 Global Contraceptives Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Contraceptives Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Contraceptives Market Facts & Figures by Country
3.3.1 North America Contraceptives Sales by Country
3.3.2 North America Contraceptives Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Contraceptives Market Facts & Figures by Country
3.4.1 Europe Contraceptives Sales by Country
3.4.2 Europe Contraceptives Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Contraceptives Market Facts & Figures by Region
3.5.1 Asia Pacific Contraceptives Sales by Region
3.5.2 Asia Pacific Contraceptives Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Contraceptives Market Facts & Figures by Country
3.6.1 Latin America Contraceptives Sales by Country
3.6.2 Latin America Contraceptives Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Contraceptives Market Facts & Figures by Country
3.7.1 Middle East and Africa Contraceptives Sales by Country
3.7.2 Middle East and Africa Contraceptives Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Contraceptives Historic Market Analysis by Type
4.1 Global Contraceptives Sales Market Share by Type (2016-2021)
4.2 Global Contraceptives Revenue Market Share by Type (2016-2021)
4.3 Global Contraceptives Price by Type (2016-2021)

5 Global Contraceptives Historic Market Analysis by Application
5.1 Global Contraceptives Sales Market Share by Application (2016-2021)
5.2 Global Contraceptives Revenue Market Share by Application (2016-2021)
5.3 Global Contraceptives Price by Application (2016-2021)

6 Key Companies Profiled
6.1 Bayer AG
6.1.1 Bayer AG Corporation Information
6.1.2 Bayer AG Description and Business Overview
6.1.3 Bayer AG Contraceptives Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Bayer AG Contraceptives Product Portfolio
6.1.5 Bayer AG Recent Developments/Updates
6.2 Pfizer, Inc
6.2.1 Pfizer, Inc Corporation Information
6.2.2 Pfizer, Inc Description and Business Overview
6.2.3 Pfizer, Inc Contraceptives Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Pfizer, Inc Contraceptives Product Portfolio
6.2.5 Pfizer, Inc Recent Developments/Updates
6.3 Teva Pharmaceutical Industries Ltd
6.3.1 Teva Pharmaceutical Industries Ltd Corporation Information
6.3.2 Teva Pharmaceutical Industries Ltd Description and Business Overview
6.3.3 Teva Pharmaceutical Industries Ltd Contraceptives Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Teva Pharmaceutical Industries Ltd Contraceptives Product Portfolio
6.3.5 Teva Pharmaceutical Industries Ltd Recent Developments/Updates
6.4 Merck & Co., Inc
6.4.1 Merck & Co., Inc Corporation Information
6.4.2 Merck & Co., Inc Description and Business Overview
6.4.3 Merck & Co., Inc Contraceptives Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Merck & Co., Inc Contraceptives Product Portfolio
6.4.5 Merck & Co., Inc Recent Developments/Updates
6.5 Actavis, Inc.
6.5.1 Actavis, Inc. Corporation Information
6.5.2 Actavis, Inc. Description and Business Overview
6.5.3 Actavis, Inc. Contraceptives Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Actavis, Inc. Contraceptives Product Portfolio
6.5.5 Actavis, Inc. Recent Developments/Updates
6.6 Johnson & Johnson
6.6.1 Johnson & Johnson Corporation Information
6.6.2 Johnson & Johnson Description and Business Overview
6.6.3 Johnson & Johnson Contraceptives Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Johnson & Johnson Contraceptives Product Portfolio
6.6.5 Johnson & Johnson Recent Developments/Updates
6.7 Gedeon Richter
6.6.1 Gedeon Richter Corporation Information
6.6.2 Gedeon Richter Description and Business Overview
6.6.3 Gedeon Richter Contraceptives Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Gedeon Richter Contraceptives Product Portfolio
6.7.5 Gedeon Richter Recent Developments/Updates
6.8 Novo Nordisk A/S
6.8.1 Novo Nordisk A/S Corporation Information
6.8.2 Novo Nordisk A/S Description and Business Overview
6.8.3 Novo Nordisk A/S Contraceptives Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Novo Nordisk A/S Contraceptives Product Portfolio
6.8.5 Novo Nordisk A/S Recent Developments/Updates
6.9 ZiZhu
6.9.1 ZiZhu Corporation Information
6.9.2 ZiZhu Description and Business Overview
6.9.3 ZiZhu Contraceptives Sales, Revenue and Gross Margin (2016-2021)
6.9.4 ZiZhu Contraceptives Product Portfolio
6.9.5 ZiZhu Recent Developments/Updates
6.10 Baijingyu
6.10.1 Baijingyu Corporation Information
6.10.2 Baijingyu Description and Business Overview
6.10.3 Baijingyu Contraceptives Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Baijingyu Contraceptives Product Portfolio
6.10.5 Baijingyu Recent Developments/Updates
6.11 Huazhong
6.11.1 Huazhong Corporation Information
6.11.2 Huazhong Contraceptives Description and Business Overview
6.11.3 Huazhong Contraceptives Sales, Revenue and Gross Margin (2016-2021)
6.11.4 Huazhong Contraceptives Product Portfolio
6.11.5 Huazhong Recent Developments/Updates
6.12 Sine
6.12.1 Sine Corporation Information
6.12.2 Sine Contraceptives Description and Business Overview
6.12.3 Sine Contraceptives Sales, Revenue and Gross Margin (2016-2021)
6.12.4 Sine Contraceptives Product Portfolio
6.12.5 Sine Recent Developments/Updates

7 Contraceptives Manufacturing Cost Analysis
7.1 Contraceptives Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Contraceptives
7.4 Contraceptives Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Contraceptives Distributors List
8.3 Contraceptives Customers

9 Contraceptives Market Dynamics
9.1 Contraceptives Industry Trends
9.2 Contraceptives Growth Drivers
9.3 Contraceptives Market Challenges
9.4 Contraceptives Market Restraints

10 Global Market Forecast
10.1 Contraceptives Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Contraceptives by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Contraceptives by Type (2022-2027)
10.2 Contraceptives Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Contraceptives by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Contraceptives by Application (2022-2027)
10.3 Contraceptives Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Contraceptives by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Contraceptives by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
List of Tables
Table 1. Global Contraceptives Sales (MT) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Contraceptives Sales (MT) Comparison by Application (2021-2027)
Table 3. Global Contraceptives Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Contraceptives Covered in This Study
Table 5. Global Contraceptives Sales (MT) of Key Manufacturers (2016-2021)
Table 6. Global Contraceptives Sales Market Share by Manufacturers (2016-2021)
Table 7. Global Contraceptives Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Contraceptives Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Contraceptives Average Price (USD/Kg) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Contraceptives Manufacturing Sites and Area Served
Table 11. Manufacturers Contraceptives Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Contraceptives by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Contraceptives as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Contraceptives Sales by Region (2016-2021) & (MT)
Table 16. Global Contraceptives Sales Market Share by Region (2016-2021)
Table 17. Global Contraceptives Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Contraceptives Sales by Country (2016-2021) & (MT)
Table 19. North America Contraceptives Sales Market Share by Country (2016-2021)
Table 20. North America Contraceptives Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Contraceptives Revenue Market Share by Country (2016-2021)
Table 22. Europe Contraceptives Sales by Country (2016-2021) & (MT)
Table 23. Europe Contraceptives Sales Market Share by Country (2016-2021)
Table 24. Europe Contraceptives Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Contraceptives Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Contraceptives Sales by Region (2016-2021) & (MT)
Table 27. Asia Pacific Contraceptives Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Contraceptives Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Contraceptives Revenue Market Share by Region (2016-2021)
Table 30. Latin America Contraceptives Sales by Country (2016-2021) & (MT)
Table 31. Latin America Contraceptives Sales Market Share by Country (2016-2021)
Table 32. Latin America Contraceptives Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Contraceptives Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Contraceptives Sales by Country (2016-2021) & (MT)
Table 35. Middle East and Africa Contraceptives Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Contraceptives Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Contraceptives Revenue Market Share by Country (2016-2021)
Table 38. Global Contraceptives Sales (MT) by Type (2016-2021)
Table 39. Global Contraceptives Sales Market Share by Type (2016-2021)
Table 40. Global Contraceptives Revenue (Million US$) by Type (2016-2021)
Table 41. Global Contraceptives Revenue Share by Type (2016-2021)
Table 42. Global Contraceptives Price (USD/Kg) by Type (2016-2021)
Table 43. Global Contraceptives Sales (MT) by Application (2016-2021)
Table 44. Global Contraceptives Sales Market Share by Application (2016-2021)
Table 45. Global Contraceptives Revenue (Million US$) by Application (2016-2021)
Table 46. Global Contraceptives Revenue Share by Application (2016-2021)
Table 47. Global Contraceptives Price (USD/Kg) by Application (2016-2021)
Table 48. Bayer AG Corporation Information
Table 49. Bayer AG Description and Business Overview
Table 50. Bayer AG Contraceptives Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 51. Bayer AG Contraceptives Product
Table 52. Bayer AG Recent Developments/Updates
Table 53. Pfizer, Inc Corporation Information
Table 54. Pfizer, Inc Description and Business Overview
Table 55. Pfizer, Inc Contraceptives Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 56. Pfizer, Inc Contraceptives Product
Table 57. Pfizer, Inc Recent Developments/Updates
Table 58. Teva Pharmaceutical Industries Ltd Corporation Information
Table 59. Teva Pharmaceutical Industries Ltd Description and Business Overview
Table 60. Teva Pharmaceutical Industries Ltd Contraceptives Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 61. Teva Pharmaceutical Industries Ltd Contraceptives Product
Table 62. Teva Pharmaceutical Industries Ltd Recent Developments/Updates
Table 63. Merck & Co., Inc Corporation Information
Table 64. Merck & Co., Inc Description and Business Overview
Table 65. Merck & Co., Inc Contraceptives Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 66. Merck & Co., Inc Contraceptives Product
Table 67. Merck & Co., Inc Recent Developments/Updates
Table 68. Actavis, Inc. Corporation Information
Table 69. Actavis, Inc. Description and Business Overview
Table 70. Actavis, Inc. Contraceptives Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 71. Actavis, Inc. Contraceptives Product
Table 72. Actavis, Inc. Recent Developments/Updates
Table 73. Johnson & Johnson Corporation Information
Table 74. Johnson & Johnson Description and Business Overview
Table 75. Johnson & Johnson Contraceptives Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 76. Johnson & Johnson Contraceptives Product
Table 77. Johnson & Johnson Recent Developments/Updates
Table 78. Gedeon Richter Corporation Information
Table 79. Gedeon Richter Description and Business Overview
Table 80. Gedeon Richter Contraceptives Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 81. Gedeon Richter Contraceptives Product
Table 82. Gedeon Richter Recent Developments/Updates
Table 83. Novo Nordisk A/S Corporation Information
Table 84. Novo Nordisk A/S Description and Business Overview
Table 85. Novo Nordisk A/S Contraceptives Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 86. Novo Nordisk A/S Contraceptives Product
Table 87. Novo Nordisk A/S Recent Developments/Updates
Table 88. ZiZhu Corporation Information
Table 89. ZiZhu Description and Business Overview
Table 90. ZiZhu Contraceptives Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 91. ZiZhu Contraceptives Product
Table 92. ZiZhu Recent Developments/Updates
Table 93. Baijingyu Corporation Information
Table 94. Baijingyu Description and Business Overview
Table 95. Baijingyu Contraceptives Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 96. Baijingyu Contraceptives Product
Table 97. Baijingyu Recent Developments/Updates
Table 98. Huazhong Corporation Information
Table 99. Huazhong Description and Business Overview
Table 100. Huazhong Contraceptives Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 101. Huazhong Contraceptives Product
Table 102. Huazhong Recent Developments/Updates
Table 103. Sine Corporation Information
Table 104. Sine Description and Business Overview
Table 105. Sine Contraceptives Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 106. Sine Contraceptives Product
Table 107. Sine Recent Developments/Updates
Table 108. Production Base and Market Concentration Rate of Raw Material
Table 109. Key Suppliers of Raw Materials
Table 110. Contraceptives Distributors List
Table 111. Contraceptives Customers List
Table 112. Contraceptives Market Trends
Table 113. Contraceptives Growth Drivers
Table 114. Contraceptives Market Challenges
Table 115. Contraceptives Market Restraints
Table 116. Global Contraceptives Sales Forecast by Type (2022-2027) & (MT)
Table 117. Global Contraceptives Sales Market Share Forecast by Type (2022-2027)
Table 118. Global Contraceptives Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 119. Global Contraceptives Revenue Market Share Forecast by Type (2022-2027)
Table 120. Global Contraceptives Sales Forecast by Application (2022-2027) & (MT)
Table 121. Global Contraceptives Sales Market Share Forecast by Application (2022-2027)
Table 122. Global Contraceptives Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 123. Global Contraceptives Revenue Market Share Forecast by Application (2022-2027)
Table 124. Global Contraceptives Sales Forecast by Region (2022-2027) & (MT)
Table 125. Global Contraceptives Sales Market Share Forecast by Region (2022-2027)
Table 126. Global Contraceptives Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 127. Global Contraceptives Revenue Market Share Forecast by Region (2022-2027)
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Contraceptives
Figure 2. Global Contraceptives Market Share by Type in 2020 & 2027
Figure 3. Prolonged Contraception Product Picture
Figure 4. Short-term Contraception Product Picture
Figure 5. Emergency Contraception Product Picture
Figure 6. Global Contraceptives Market Share by Application in 2020 & 2027
Figure 7. Hospital Pharmacies
Figure 8. Retail Pharmacies
Figure 9. Online Pharmacies
Figure 10. Others
Figure 11. Global Contraceptives Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Contraceptives Market Size 2016-2027 (US$ Million)
Figure 13. Global Contraceptives Sales 2016-2027 (MT)
Figure 14. Global Contraceptives Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 15. Contraceptives Sales Share by Manufacturers in 2020
Figure 16. Global Contraceptives Revenue Share by Manufacturers in 2020
Figure 17. The Global 5 and 10 Largest Contraceptives Players: Market Share by Revenue in 2020
Figure 18. Contraceptives Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 19. Global Contraceptives Sales Market Share by Region (2016-2021)
Figure 20. Global Contraceptives Sales Market Share by Region in 2020
Figure 21. Global Contraceptives Revenue Market Share by Region (2016-2021)
Figure 22. Global Contraceptives Revenue Market Share by Region in 2020
Figure 23. U.S. Contraceptives Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. Canada Contraceptives Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. Germany Contraceptives Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. France Contraceptives Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. U.K. Contraceptives Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Italy Contraceptives Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Russia Contraceptives Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. China Contraceptives Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. Japan Contraceptives Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. South Korea Contraceptives Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. India Contraceptives Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Australia Contraceptives Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Taiwan Contraceptives Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Indonesia Contraceptives Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Thailand Contraceptives Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Malaysia Contraceptives Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Philippines Contraceptives Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Vietnam Contraceptives Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Mexico Contraceptives Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Brazil Contraceptives Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Argentina Contraceptives Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Turkey Contraceptives Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Saudi Arabia Contraceptives Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. U.A.E Contraceptives Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. Sales Market Share of Contraceptives by Type (2016-2021)
Figure 48. Sales Market Share of Contraceptives by Application (2016-2021)
Figure 49. Sales Market Share of Contraceptives by Application in 2020
Figure 50. Revenue Share of Contraceptives by Application (2016-2021)
Figure 51. Revenue Share of Contraceptives by Application in 2020
Figure 52. Manufacturing Cost Structure of Contraceptives
Figure 53. Manufacturing Process Analysis of Contraceptives
Figure 54. Contraceptives Industrial Chain Analysis
Figure 55. Channels of Distribution
Figure 56. Distributors Profiles
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’